Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maha Othman

Showing results (21-30 of 142) with videos related to

Pageof 15
Sort By:
Seminars in Thrombosis and Hemostasis|June 23, 2026
Red Blood Cells in Hemostasis and Thrombosis: Mechanisms, Interactions, and Clinical ImplicationsRegan Bucciol, Maha Othman
Research and Practice in Thrombosis and Haemostasis|August 21, 2023
Comparison of 2 ways of performing ristocetin-induced platelet agglutination mixing study for diagnosis of type 2B von Willebrand disease. Response to the publication of Soleimani et alEmmanuel J Favaloro, Maha Othman
British Journal of Anaesthesia|April 30, 2021
Obstetric neuraxial anaesthesia in the setting of immune thrombocytopenia and low platelet counts: call to participate in an international registryAnn Kinga Malinowski, Maha Othman, , et al.
Research and Practice in Thrombosis and Haemostasis|January 3, 2022
2B von Willebrand disease diagnosis: Considerations reflecting on 2021 multisociety guidelinesMaha Othman, Emmanuel J Favaloro
Seminars in Thrombosis and Hemostasis|October 2, 2019
Molecular and Genetic Testing in Thrombosis and HemostasisDavid John Rabbolini, Maha Othman
Seminars in Thrombosis and Hemostasis|December 17, 2008
Genetics of type 2B von Willebrand disease: "true 2B," "tricky 2B," or "not 2B." What are the modifiers of the phenotype?Maha Othman, Emmanuel J Favaloro
Cureus|August 27, 2025
Optimal Cutoff for the Neutrophil-to-Lymphocyte Ratio as a Tool for Pre-chemotherapy Prognosis Stratification of Breast Cancer PatientsArmita Zandi, Alyssa Qian, Maha Othman
Virology Journal|October 4, 2011
Human platelets express CAR with localization at the sites of intercellular interactionElena Gupalo, Liudmila Buriachkovskaia, Maha Othman
Acta Haematologica|December 4, 2013
Acquired von Willebrand syndrome with a type 2B phenotype: diagnostic and therapeutic dilemmasEllen Scepansky, Maha Othman, Hedy Smith
Seminars in Thrombosis and Hemostasis|August 13, 2013
Platelet-type von Willebrand disease: new insights into the molecular pathophysiology of a unique platelet defectMaha Othman, Harmanpreet Kaur, Jonas Emsley
Pageof 15

Showing results (21-30 of 142) with videos related to

Sort By:
Pageof 15
Seminars in Thrombosis and Hemostasis|June 23, 2026
Red Blood Cells in Hemostasis and Thrombosis: Mechanisms, Interactions, and Clinical ImplicationsRegan Bucciol, Maha Othman
Research and Practice in Thrombosis and Haemostasis|August 21, 2023
Comparison of 2 ways of performing ristocetin-induced platelet agglutination mixing study for diagnosis of type 2B von Willebrand disease. Response to the publication of Soleimani et alEmmanuel J Favaloro, Maha Othman
British Journal of Anaesthesia|April 30, 2021
Obstetric neuraxial anaesthesia in the setting of immune thrombocytopenia and low platelet counts: call to participate in an international registryAnn Kinga Malinowski, Maha Othman, , et al.
Research and Practice in Thrombosis and Haemostasis|January 3, 2022
2B von Willebrand disease diagnosis: Considerations reflecting on 2021 multisociety guidelinesMaha Othman, Emmanuel J Favaloro
Seminars in Thrombosis and Hemostasis|October 2, 2019
Molecular and Genetic Testing in Thrombosis and HemostasisDavid John Rabbolini, Maha Othman
Seminars in Thrombosis and Hemostasis|December 17, 2008
Genetics of type 2B von Willebrand disease: "true 2B," "tricky 2B," or "not 2B." What are the modifiers of the phenotype?Maha Othman, Emmanuel J Favaloro
Cureus|August 27, 2025
Optimal Cutoff for the Neutrophil-to-Lymphocyte Ratio as a Tool for Pre-chemotherapy Prognosis Stratification of Breast Cancer PatientsArmita Zandi, Alyssa Qian, Maha Othman
Virology Journal|October 4, 2011
Human platelets express CAR with localization at the sites of intercellular interactionElena Gupalo, Liudmila Buriachkovskaia, Maha Othman
Acta Haematologica|December 4, 2013
Acquired von Willebrand syndrome with a type 2B phenotype: diagnostic and therapeutic dilemmasEllen Scepansky, Maha Othman, Hedy Smith
Seminars in Thrombosis and Hemostasis|August 13, 2013
Platelet-type von Willebrand disease: new insights into the molecular pathophysiology of a unique platelet defectMaha Othman, Harmanpreet Kaur, Jonas Emsley
Pageof 15